Blog Immunotherapy 360: Checkpoint Inhibitors

Checkpoint Inhibitors

The Immunotherapy 360 blog space features articles that encompass prominent issues related to immunotherapy. These are written with the assistance of the staff at AIM at Melanoma, AIM with Immunotherapy and health care practitioners.

If you have an idea for a future article, please reach out to us on our contact page!

Featured image for “What’s the Issue of Concurrent Statins During Immune Checkpoint Inhibitor Therapy?”

What’s the Issue of Concurrent Statins During Immune Checkpoint Inhibitor Therapy?

May 28, 2025
Introduction Recently, published studies have sparked discussion about combining statins with immune checkpoint inhibitors during cancer treatment. The Journal of…

Recent Posts

Featured image for “Experiencing the Worst Effects Indicates the Best News for Patients”
Jun. 04, 2025

Experiencing the Worst Effects Indicates the Best News for Patients

Featured image for “What’s the Issue of Concurrent Statins During Immune Checkpoint Inhibitor Therapy?”
May. 28, 2025

What’s the Issue of Concurrent Statins During Immune Checkpoint Inhibitor Therapy?

Featured image for “Ocular Toxicities Associated with Vedotins and Other Antibody-Drug Conjugates are Manageable”
Apr. 23, 2025

Ocular Toxicities Associated with Vedotins and Other Antibody-Drug Conjugates are Manageable

Post Categories